Evaluating hemodynamic stability in septic shock patients using a new dialysis membrane

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effectiveness of the oXiris membrane in continuous renal replacement therapy (CRRT) for patients suffering from severe acute kidney injury due to sepsis. It aims to compare the hemodynamic stability and patient outcomes, such as cardiovascular and renal function, between the oXiris membrane and standard polysulfone membranes. The study utilizes a real-time monitoring registry to gather data on cytokine and endotoxin removal rates, as well as overall survival rates. The goal is to determine if the oXiris membrane can provide better clinical outcomes than traditional methods.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged ≥ 18 years
* Sepsis related acute kidney injury requiring continuous renal replacement therapy

Exclusion Criteria:

• No monitoring of blood pressure and ECG

Where it's running

• Seoul National University Hospital
  Seoul, South Korea Recruiting

Study contacts

• Principal investigator: Seung Seok Han, M.D. — Seoul National University Hospital
• Study coordinator: Seung Seok Han, M.D.
• Email: hansway7@snu.ac.kr
• Phone: 82-2-2072-4785

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gut microbes and blood signals in sepsis-related liver and kidney injury

  This study tests whether gut microbes and blood markers differ in adults with sepsis who develop liver or kidney injury, compared with healthy volunteers.

  Recruiting at 6 sites First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 5 other locations · NCT07735182

• Registry for pediatric patients with acute kidney injury due to sepsis receiving QUELIMMUNE

  This study is looking to see if a treatment called QUELIMMUNE is safe for kids with kidney injury from sepsis and if it helps reduce new infections compared to those getting standard kidney treatment.

  Recruiting at 15 sites SeaStar Medical · Birmingham, Alabama and 14 other locations · NCT06517810

• Prebiotic and Probiotic Combo for Constipation Symptoms

  This study tests whether adding 1-kestose to a probiotic (BBH112) helps adults with constipation-related symptoms see more relief and better quality of life.

  Recruiting Seoul National University Hospital · Seongnam-si, Gyeonggi-do · NCT07923279

• Rehabilitation data registry for spinal cord injury in Korea

  This study tests whether long‑term disability and function after spinal cord injury can be predicted by combining medical and socioeconomic information gathered during and after inpatient rehabilitation.

  Recruiting Seoul National University Hospital · Yangpyeong, Gyeonggi-do · NCT07901985

• RSV vaccine safety and immune response in lung transplant patients vs. healthy adults

  This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.

  Recruiting Phase 4 Seoul National University Hospital · Seoul, Jongno-Gu · NCT07895394

• CD19 CAR-T Therapy for Kids with Refractory Childhood SLE

  This study tests whether a patient’s own CD19 CAR-T cells can help children and young adults with severe, hard-to-treat lupus.

  Recruiting Phase 1 Seoul National University Hospital · Seoul · NCT07855302

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.